- Clinical Trials
- January 2024
- 60 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1434EUR$1,500USD£1,200GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1195EUR$1,250USD£1,000GBP
- Book
- September 2024
- 224 Pages
- Book
- September 2020
- 560 Pages
Demethylases are a type of enzyme that catalyzes the removal of methyl groups from DNA and histones. This process is known as demethylation and is important for gene expression and epigenetic regulation. Demethylases are involved in a variety of biological processes, including development, differentiation, and disease.
Demethylases are used in a variety of research and clinical applications, including drug discovery, gene therapy, and cancer research. They are also used in the production of biopharmaceuticals, such as monoclonal antibodies and recombinant proteins.
The demethylase market is growing rapidly due to increasing demand for biopharmaceuticals and the development of new technologies. The market is expected to be driven by the increasing prevalence of cancer and other diseases, as well as the development of new therapeutic strategies.
Some of the major companies in the demethylase market include Merck KGaA, Abcam, Thermo Fisher Scientific, New England Biolabs, and Sigma-Aldrich. Show Less Read more